Serevent and Cholecystitis - a phase IV clinical study of FDA data

Summary:

Cholecystitis is reported as a side effect among people who take Serevent (salmeterol xinafoate), especially for people who are female, 60+ old, also take Flovent, and have Depression.

The phase IV clinical study analyzes which people have Cholecystitis when taking Serevent. It is created by eHealthMe based on reports of 15,422 people who have side effects when taking Serevent from the FDA, and is updated regularly.

What is Serevent?

Serevent has active ingredients of salmeterol xinafoate. It is often used in asthma. eHealthMe is studying from 15,586 Serevent users. Check the latest studies of Serevent.

What is Cholecystitis?

Cholecystitis (infection of gallbladder) is found to be associated with 1,181 drugs and 1,217 conditions by eHealthMe. Check the latest studies of Cholecystitis.

On Jul, 22, 2026

15,422 people reported to have side effects when taking Serevent.
Among them, 40 people (0.26%) have Cholecystitis.

Among these 40 people:

What is the gender of people who have Cholecystitis when taking Serevent? *

female: 70 %
male: 30 %

What is the age of people who have Cholecystitis when taking Serevent? *

What are other drugs people take besides Serevent? *

What are other side effects people have besides Cholecystitis? *

Gallstones (stone formation by bile component): 21 people, 52.50%
Fever: 14 people, 35.00%
Fatigue (feeling of tiredness): 14 people, 35.00%
Chest Pain: 14 people, 35.00%
Weakness: 13 people, 32.50%
Stress And Anxiety: 13 people, 32.50%
Pleural Effusion (water on the lungs): 12 people, 30.00%
Abdominal Pain: 12 people, 30.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 12 people, 30.00%
Depression: 12 people, 30.00%

What are the existing conditions these people have? *

High Blood Cholesterol: 3 people, 7.50%
Bipolar Disorder (mood disorder): 3 people, 7.50%
Sleep Disorder: 3 people, 7.50%
Depression: 3 people, 7.50%
Wound: 2 people, 5.00%
Oedema (fluid collection in tissue): 2 people, 5.00%
Swelling: 2 people, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 2.50%
Oesophageal Carcinoma (cancer tumour of oesophagus): 1 person, 2.50%
Urinary Tract Infection: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Serevent and have Cholecystitis?

- Check whether Cholecystitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serevent:

Serevent (15,586 reports)

Cholecystitis treatments and more:

Cholecystitis (16,481 reports)

Browse all side effects of Serevent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis:

Cholecystitis (1,181 drugs)

Browse all the conditions that are associated with Cholecystitis:

Cholecystitis (1,217 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on salmeterol xinafoate (the active ingredients of Serevent) and Serevent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.